274 related articles for article (PubMed ID: 34236626)
21. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
Chen H; Wei L; Luo M; Wang X; Zhu C; Huang H; Liu X; Lu H; Zhong Y
Cell Biol Toxicol; 2022 Dec; 38(6):995-1011. PubMed ID: 34322788
[TBL] [Abstract][Full Text] [Related]
22. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
[TBL] [Abstract][Full Text] [Related]
23. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway.
Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B
Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387
[TBL] [Abstract][Full Text] [Related]
24. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
25. The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.
Lv B; Li F; Liu X; Lin L
Cancer Gene Ther; 2021 Feb; 28(1-2):74-88. PubMed ID: 32555352
[TBL] [Abstract][Full Text] [Related]
26. Regulatory role of miRNAs in nasopharyngeal cancer involving PTEN/PI3K/AKT, TGFβ/SMAD, RAS/MAPK, Wnt/β-catenin and pRB-E2F signaling pathways: A review.
S M N Mydin RB; Azlan A; Okekpa SI; Gooderham NJ
Cell Biochem Funct; 2024 Mar; 42(2):e3945. PubMed ID: 38362935
[TBL] [Abstract][Full Text] [Related]
27. Relationship of PI3K-Akt/mTOR/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma.
Chen Y; He Q; Ma H; Zhang L; Liu F; Han Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):165-173. PubMed ID: 35545406
[TBL] [Abstract][Full Text] [Related]
28. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
29. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
[TBL] [Abstract][Full Text] [Related]
31. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Xie Z; Li W; Ai J; Xie J; Zhang X
J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
[TBL] [Abstract][Full Text] [Related]
32. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
33. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-FOXO3a signaling.
Wu S; Xie DL; Dai XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7391-7398. PubMed ID: 31539126
[TBL] [Abstract][Full Text] [Related]
35. Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.
Liu J; Huang W; Ren C; Wen Q; Liu W; Yang X; Wang L; Zhu B; Zeng L; Feng X; Zhang C; Chen H; Jia W; Zhang L; Xia X; Chen Y
Sci Rep; 2015 Jul; 5():11614. PubMed ID: 26206082
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
Li DP; Chai W; Liu YH; Xu TT; Huang H
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
[TBL] [Abstract][Full Text] [Related]
37. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
38. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
Zhang W; Zhang Q; Cui Q; Xu Y
Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
